About Us





LONVI

Biomarker driven Senotherapeutic


A longevity-focused biotechnology company specializing in targeted interventions for senescent cells. With a top interdisciplinary R&D team, proprietary development platforms, and multiple core patents, we have successfully developed anti-aging ingredients and technologies including Senolytics, Senomorphics, and Senoreverse strategies.

Research & Development Focus

01

Proprietary Senotherapeutic Development Platform

Global Pioneer in Proanthocyanidin Development

Through innovative tangential flow nanofiltration systems and solid-phase adsorption coupled with graded separation processes, we have overcome long-standing production bottlenecks in cost efficiency and high-purity extraction.

  • Proprietary production of dietary supplements and pharmaceutical-grade ingredients, including oligomeric proanthocyanidins with purity ranging from 10% to 90%
  • Exclusive production technologies for senotherapeutic components including Senomorphic procyanidin B2 and dual-mode proanthocyanidin C1
02

Senoreverse Technology Development

Cutting-Edge Gene Therapy Solutions

  • Advanced microfluidic technologies and high-throughput drug screening systems for precise single-cell level selection
  • Development of organ-on-a-chip models based on human primary cells to simulate biomimetic senescent dermal tissue
  • Green-ingredient-based nano-delivery platform supporting targeted delivery of linear mRNA and miRNA
03

At-Home Aging Biomarker Detection

Innovative Sampling and Analysis Solutions

  • Microfluidic capillary blood collection technology with proprietary NAD stabilization methods for reliable biomarker analysis
  • Evolving detection technologies covering metabolic, nutritional, and systemic homeostasis assessments
  • At-home testing devices for long-term monitoring of aging-related indicators including hormones, insulin, and inflammatory factors

Data-Driven Anti-Aging Interventions

At LONVI, we are committed to building a closed-loop system: senotherapeutic regimens → dynamic tracking → iterative optimization of interventions. By integrating our proprietary senotherapeutic technologies with at-home detection capabilities for aging-related biomarkers, we provide customers with data-driven personalized nutritional supplements and intervention plans.